The global cardiac biomarkers market size was valued at USD 18.62 billion in 2024. The market is projected to grow from USD 20.90 billion in 2025 to USD 47.43 billion by 2032, exhibiting a CAGR of 12.4% during the forecast period. North America dominated the cardiac biomarkers market with a market share of 39.09% in 2024.

Market Overview

The cardiac biomarkers market ****is experiencing transformative growth, driven by healthcare technology innovations, expanding digital ecosystems, and a rising focus on preventive and personalized medicine. Between 2019  and 2032, the industry is projected to expand significantly, supported by higher healthcare budgets, evolving patient expectations, and growing investments in infrastructure and research.

Demographic shifts—including aging populations, urbanization, and the rising prevalence of chronic diseases—are further accelerating demand for advanced healthcare services and solutions worldwide.

cardiac biomarkers market represents a broad set of products, solutions, and services that enhance care delivery, improve safety, and ensure compliance. These solutions are crucial for reducing risks, protecting patients, enhancing diagnostic and treatment efficiency, and maintaining regulatory adherence.

Continue reading for more details:

https://www.fortunebusinessinsights.com/cardiac-biomarkers-market-101233

Key Market Drivers

  1. Rising Patient Safety Concerns – Demand for tools that prevent medical errors and infections.
  2. Technological Advancements – Integration of AI, analytics, and automation for efficiency.
  3. Healthcare Expenditure Growth – Investments in infrastructure upgrades by governments and private players.
  4. Regulatory Pressure – Strict global safety standards driving adoption.
  5. Expansion in Emerging Markets – Improved healthcare infrastructure in Asia-Pacific, Latin America, and Africa.

Cardiac Biomarkers Market.PNG

Market Segmentation

The cardiac biomarkers market can be segmented as follows:

  1. Key Findings / Summary
  2. Market Analysis, Insights and Forecast – By Indication
    1. Myocardial Infarction
    2. Congestive Heart Failure
    3. Acute Coronary Syndrome
    4. Others
  3. Market Analysis, Insights and Forecast – By Biomarkers
    1. Troponin
    2. Creatine kinase-MB (CK-MB)
    3. B-type natriuretic peptide (BNP)
    4. Myoglobin
    5. Others